PTC Therapeutics, Inc.
PTC Therapeutics is a global biopharmaceutical company dedicated to transforming lives by developing innovative therapies for people living with rare diseases. With 25 years of scientific expertise, the company focuses on research platforms such as splicing and inflammation & ferroptosis to create groundbreaking treatments. PTC is committed to patient-centric approaches, clinical research, and making a positive impact on communities and the environment.
Industries
Nr. of Employees
Very Large (1000+)
PTC Therapeutics, Inc.
South Plainfield, New Jersey, United States, North America
Products
Sephience™ (sepiapterin)
A treatment for phenylketonuria (PKU) granted marketing authorization in Europe for children and adults.
Translarna™ (ataluren)
An approved medicine for Duchenne muscular dystrophy caused by a nonsense mutation.
Emflaza® (deflazacort)
An approved treatment for Duchenne muscular dystrophy.
Sephience™ (sepiapterin)
A treatment for phenylketonuria (PKU) granted marketing authorization in Europe for children and adults.
Translarna™ (ataluren)
An approved medicine for Duchenne muscular dystrophy caused by a nonsense mutation.
Emflaza® (deflazacort)
An approved treatment for Duchenne muscular dystrophy.
Services
Healthcare Provider Resources
Supporting healthcare providers with scientific information and resources to improve patient care.
Patient & Caregiver Resources
Providing support and educational materials for patients and families living with rare diseases.
Investor Relations Support
Offering information and updates for investors interested in PTC's developments.
Clinical Trials
Conducting and supporting clinical research to develop new treatments for rare diseases.
Healthcare Provider Resources
Supporting healthcare providers with scientific information and resources to improve patient care.
Patient & Caregiver Resources
Providing support and educational materials for patients and families living with rare diseases.
Investor Relations Support
Offering information and updates for investors interested in PTC's developments.
Clinical Trials
Conducting and supporting clinical research to develop new treatments for rare diseases.